UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Assessing the individual benefits of reducing HIV diagnosis delay and increasing adherence to HIV care and treatment

AIDS care, 2023-07, Vol.35 (7), p.1007-1013

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States

Journal of acquired immune deficiency syndromes (1999), 2016-03, Vol.71 (3), p.323

2016

Link zum Volltext

Verfügbarkeit prüfen

Progression and transmission of HIV (PATH 4.0)-A new agent-based evolving network simulation for modeling HIV transmission clusters

Mathematical biosciences and engineering : MBE, 2021-03, Vol.18 (3), p.2150-2181

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost Effectiveness of HIV Prevention Interventions in the U.S

American journal of preventive medicine, 2016-06, Vol.50 (6), p.699-708

2016

Link zum Volltext

Verfügbarkeit prüfen

Optimal allocation of HIV prevention funds for state health departments

PloS one, 2018-05, Vol.13 (5), p.e0197421-e0197421

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings

PLoS medicine, 2010-09, Vol.7 (9), p.e1000342-e1000342

2010

Link zum Volltext

Verfügbarkeit prüfen

Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the United States

AIDS (London), 2023-06, Vol.37 (7), p.1147

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis

PloS one, 2011-05, Vol.6 (5), p.e19936-e19936

2011

Link zum Volltext

Verfügbarkeit prüfen

COVID-19-related excess missed HIV diagnoses in the United States in 2021

AIDS (London), 2024-05, Vol.38 (6), p.907

2024

Link zum Volltext

Verfügbarkeit prüfen

The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018

Sexually transmitted diseases, 2021-04, Vol.48 (4), p.215-221

2021

Link zum Volltext

Verfügbarkeit prüfen

Estimated Lifetime HIV-Related Medical Costs in the United States

Sexually transmitted diseases, 2021-04, Vol.48 (4), p.299-304

2021

Link zum Volltext

Verfügbarkeit prüfen

Mortality Among Persons With HIV in the United States During the COVID-19 Pandemic: A Population-Level Analysis

Journal of acquired immune deficiency syndromes (1999), 2024-02, Vol.95 (2), p.126

2024

Link zum Volltext

Verfügbarkeit prüfen

Simulation of Full HIV Cluster Networks in a Nationally Representative Model Indicates Intervention Opportunities

Journal of acquired immune deficiency syndromes (1999), 2024-04, Vol.95 (4), p.355

2024

Link zum Volltext

Verfügbarkeit prüfen

Progression and Transmission of HIV/AIDS (PATH 2.0): A New, Agent-Based Model to Estimate HIV Transmissions in the United States

Medical decision making, 2017-02, Vol.37 (2), p.224-233

2017

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Cost-Effectiveness of HIV Self-Testing in the United States Using Net Benefit Regression

Journal of acquired immune deficiency syndromes (1999), 2024-02, Vol.95 (2), p.138

2024

Link zum Volltext

Verfügbarkeit prüfen

Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis

Journal of acquired immune deficiency syndromes (1999), 2021-12, Vol.88 (4), p.e28

2021

Link zum Volltext

Verfügbarkeit prüfen

Isolating the Effect of COVID-19-Related Disruptions on HIV Diagnoses in the United States in 2020

Journal of acquired immune deficiency syndromes (1999), 2023-04, Vol.92 (4), p.293

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessing the Impact of COVID-19 on HIV Outcomes in the United States: A Modeling Study

Sexually transmitted diseases, 2024-04, Vol.51 (4), p.299

2024

Link zum Volltext

Verfügbarkeit prüfen

Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care

Journal of acquired immune deficiency syndromes (1999), 2013-10, Vol.64 (2), p.183

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets

Journal of acquired immune deficiency syndromes (1999), 2022-04, Vol.89 (4), p.374

2022

Link zum Volltext

Verfügbarkeit prüfen

Combinations of interventions to achieve a national HIV incidence reduction goal: insights from an agent-based model

AIDS (London), 2017-11, Vol.31 (18), p.2533-2539

2017

Link zum Volltext

Verfügbarkeit prüfen

The Estimated Number and Lifetime Medical Cost of HIV Infections Attributable to Sexually Transmitted Infections Acquired in the United States in 2018: A Compilation of Published Modeling Results

Sexually transmitted diseases, 2021-04, Vol.48 (4), p.292-298

2021

Link zum Volltext

Verfügbarkeit prüfen

Estimating the HIV Effective Reproduction Number in the United States and Evaluating HIV Elimination Strategies

Journal of public health management and practice, 2022-03, Vol.28 (2), p.152

2022

Link zum Volltext

Verfügbarkeit prüfen

Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era

Journal of acquired immune deficiency syndromes (1999), 2013-10, Vol.64 (2), p.e15

2013

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons

Journal of acquired immune deficiency syndromes (1999), 2012-09, Vol.61 (1), p.99

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(89)
Reviews
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(50)
Humans
(44)
Human Immunodeficiency Virus
(34)
Hiv
(32)
Infectious Diseases
(27)
Hiv Infections - Economics
(26)
United States
(23)
Aids/hiv
(21)
Immunology
(21)
Hiv Infections - Prevention & Control
(19)
Hiv Infections - Diagnosis
(18)
Social Sciences
(17)
Hiv Infections - Epidemiology
(16)
Male
(16)
Aids
(15)
Biological And Medical Sciences
(15)
Cost-Benefit Analysis
(14)
Medical Sciences
(14)
Acquired Immune Deficiency Syndrome
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessing the individual benefits of reducing HIV diagnosis delay and increasing adherence to HIV care and treatment

Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States

Progression and transmission of HIV (PATH 4.0)-A new agent-based evolving network simulation for modeling HIV transmission clusters

Cost Effectiveness of HIV Prevention Interventions in the U.S

Optimal allocation of HIV prevention funds for state health departments

Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings

Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the United States

Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis

COVID-19-related excess missed HIV diagnoses in the United States in 2021

The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018

Estimated Lifetime HIV-Related Medical Costs in the United States

Mortality Among Persons With HIV in the United States During the COVID-19 Pandemic: A Population-Level Analysis

Simulation of Full HIV Cluster Networks in a Nationally Representative Model Indicates Intervention Opportunities

Progression and Transmission of HIV/AIDS (PATH 2.0): A New, Agent-Based Model to Estimate HIV Transmissions in the United States

Estimating the Cost-Effectiveness of HIV Self-Testing in the United States Using Net Benefit Regression

Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis

Isolating the Effect of COVID-19-Related Disruptions on HIV Diagnoses in the United States in 2020

Assessing the Impact of COVID-19 on HIV Outcomes in the United States: A Modeling Study

Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care

Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets

Combinations of interventions to achieve a national HIV incidence reduction goal: insights from an agent-based model

The Estimated Number and Lifetime Medical Cost of HIV Infections Attributable to Sexually Transmitted Infections Acquired in the United States in 2018: A Compilation of Published Modeling Results

Estimating the HIV Effective Reproduction Number in the United States and Evaluating HIV Elimination Strategies

Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era

Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons

Suchergebnisse filtern